Agilent Announces Agreement with Picometrics Technologies
News Jan 17, 2014
In addition to classic CE-LIF analysis technology, this collection of tools provides the only online CE-LIF-MS solution available today. The platform is ideally suited for the research and development of complex large-molecule biopharmaceutical compounds.
"We are very pleased to extend a long-standing and fruitful partnership with Agilent and consolidate our development strategy," said Jean Charles Garcia, president of Picometrics. "This unique technological platform using our new-generation LIF detection will significantly increase efficiency for biotherapeutic characterization in research, development and quality control."
"We are excited to collaborate with Picometrics and provide this unique product offering to the biopharmaceutical industry-particularly those focusing on the research and development of NBEs, or new biological entities," said Michael Frank, Agilent marketing director, liquid phase separations. "As conventional drug research becomes outmoded in meeting the increasing demands of complex, large-molecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery."
A number of Agilent products can be combined with Picometrics ZETALIF LED and ZETALIF LASER instruments, including Agilent's Capillary Electrophoresis and CE/MS technologies, as well as HPLC/UHPLC solutions. For more information on this combined product offering, visit Agilent's CE-LIF solutions website.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
18th International Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques
Nov 02 - Nov 03, 2017
8th Edition of International Conference on Mass Spectromerty
Mar 12 - Mar 13, 2018